Boehringer Ingelheim Cares Foundation Inc.

The Boehringer Ingelheim Cares Foundation operates as the philanthropic arm of Boehringer Ingelheim, one of the world largest privately-owned pharmaceutical companies. The foundation has two distinct operational modes: (1) a massive product donation program valued at over $1 billion annually, providing Boehringer Ingelheim medicines free of charge to eligible uninsured and underinsured US patients and disaster relief recipients; and (2) a much smaller cash grantmaking program (~$1.6M annually) focused on community organizations. The cash grants target three specific areas: improving healthcare access for underserved populations, enhancing STEM education, and strengthening the human-animal bond through animal-assisted therapies. Connecticut serves as the geographic priority for cash grants, reflecting the company US headquarters location in Ridgefield, CT. The foundation approach is distinctly corporate-philanthropic — leveraging the parent company pharmaceutical assets for patient access while making targeted community investments in its headquarters region. The Financial Contributions Program operates on an annual cycle with an April 1 deadline, making it more structured than many private foundations rolling approaches.

The foundation financial profile is dominated by product donations rather than cash grants. In recent filings, product donations for the Patient Assistance Program totaled approximately $849.6 million, disaster relief product donations reached $179.8 million, and cash grants to charitable organizations were approximately $1.6 million — making the foundation one of the largest in the country by total value distributed but modest in cash grantmaking. The foundation holds $252 million in assets. Cash grants are deliberately targeted at smaller community organizations rather than large institutions. Known grantees include Connecticut-based healthcare providers (Malta House of Care in Hartford, Americares Free Clinics in Fairfield County, Danbury and New Milford Hospitals, Norma F. Pfriem Breast Care Center) and national organizations aligned with its mission (Angel Flight of New England, Cancer Care Inc.). The concentration of cash grants in healthcare access, STEM education, and animal-assisted therapy creates a narrow but distinctive funding niche. Geographic distribution heavily favors Connecticut, though grants have gone to organizations in other US regions.

Among pharmaceutical corporate foundations, the Boehringer Ingelheim Cares Foundation is unique for the enormous scale of its product donation programs (over $1 billion annually) compared to its modest cash grantmaking (~$1.6M). Most pharma foundations like Pfizer ($40M cash), J&J ($100M), and Merck ($15M) invest far more in cash grants. This reflects Boehringer Ingelheim status as a privately-held company (the Boehringer and Von Baumbach families) versus publicly-traded peers with larger CSR budgets. The foundation Connecticut focus also distinguishes it from peers that typically fund nationally. For community organizations in Connecticut seeking healthcare-related funding, the BI Cares Foundation represents a distinctive local resource, though applicants should be aware that cash grant amounts are relatively small compared to the foundation total reported giving.

The Boehringer Ingelheim Cares Foundation continues its massive Patient Assistance Program, providing Boehringer Ingelheim medications at no cost to eligible US patients. Product donations for patient assistance were valued at approximately $849.6 million in recent filings, with an additional $179.8 million in product donations for disaster relief globally. The Financial Contributions Program awarded approximately $1.6 million in cash grants to charitable organizations, with an estimated April 1, 2026 deadline for the current cycle. The foundation has been a consistent supporter of Connecticut healthcare institutions including Malta House of Care in Hartford and Americares Free Clinics in Fairfield County. National grants have supported Angel Flight of New England for medical air transport and Cancer Care Inc. for patient support services. The foundation maintains its three core grantmaking pillars: healthcare access for underserved populations, STEM education, and the human-animal bond. The parent company Boehringer Ingelheim continues to maintain its US headquarters in Ridgefield, CT, anchoring the foundation local philanthropic footprint.

To successfully apply to the Boehringer Ingelheim Cares Foundation Financial Contributions Program: (1) Submit your application by April 1 annually — this is a firm deadline, not rolling; (2) Organizations based in or serving Connecticut have the strongest positioning, as this is the geographic priority; (3) Focus your proposal on one of three areas: healthcare access for underinsured/underserved populations, STEM education programs, or animal-assisted therapy initiatives — the foundation does not fund outside these areas; (4) The foundation favors smaller organizations over large institutions — demonstrate community-level impact; (5) Apply through the online portal at bicares.boehringer-ingelheim.com; (6) For questions, contact 203-798-4895 or email bicaresfoundation.rdg@boehringer-ingelheim.com; (7) Be realistic about grant amounts — cash grants total approximately $1.6M across all grantees annually, so individual awards are typically modest; (8) The Patient Assistance Program is a separate program for individual patients, not organizations — do not confuse the two; (9) Healthcare organizations should highlight the population served and barriers to access; (10) STEM education applicants should demonstrate engagement with underserved youth. The foundation address is in Ridgefield, CT (Boehringer Ingelheim US headquarters). Note that the main website boehringer-ingelheim.com is the corporate site, not the foundation-specific portal.